CJC-1295 + ipamorelin blend user experiences: what users themselves report

Users’ own accounts, not research. The accounts are self-selected and prove neither that it works nor that it is safe.

This page does not list users’ doses or sellers, and no figure on it is a recommendation. Doses used in studies, with sources: CJC-1295 + ipamorelin blend dosage in studies.

In short

Of 84 people, 33 (39%) said the CJC-1295 + ipamorelin blend brought some benefit and 60 (71%) some harm.

Where the accounts come from and how we read them

Sources: the Reddit forums r/Peptides (65 accounts), r/Biohackers (19), r/Nootropics (1) and r/Retatrutide (1), 16 Oct 2024 to 4 Oct 2026. The posts were retrieved from a public Reddit archive. From first-person posts about the CJC-1295 + ipamorelin blend, 300 were picked at random, and every one was read.

Coding: for each account we recorded the route, reported benefits and harms, how strong a harm was, whether and why the person stopped, length of use and other substances used at the same time. We kept accounts that reported some effect, some harm, or no effect. Questions and plans were left out. A harm was recorded when the person reported it during use, even if the cause was uncertain. Several posts by one person count as one person. One person can mention several things, so the shares in the tables do not add up to 100.

Check: an AI model read and classified the posts following written instructions. A second, separate AI run classified a random tenth (30 posts) again without seeing the first classification. The main fields matched: 29/30 (97%). 2 posts looked like marketing and are not in the figures.

Whose accounts these are: routes mentioned: injection 38; the others did not say. The figures describe the writers and are not a recommendation. The products were not verified, so we do not know what people actually took.

Did the CJC-1295 + ipamorelin blend help? The overall picture

Of 84 people, 21 (25%) reported benefit only, 12 (14%) both benefit and harm, 48 (57%) harm only and 3 (4%) neither.

Stopping. 13 people (15%) said they stopped or paused: 12 because of harms and 1 because they noticed no effect or for another reason.

Share = people / 84.
Overall picture: benefit, harm or neitherPeopleShare
Benefit only2125%
Both benefit and harm1214%
Harm only4857%
Neither benefit nor harm34%

Most common reported benefits

Of 84 people. 33 (39%) mentioned some benefit; the table lists every benefit reported.

ReportedPeopleShare
Better sleep1518%
Fat loss or smaller waist1214%
Muscle or strength1214%
Energy or alertness34%
Mood or wellbeing34%
IGF-1 rose on a lab test22%
Faster recovery11%
Skin, hair or nails11%
Other benefit78%

Share = people / 84.

Most common reported harms

Of 84 people. 60 (71%) mentioned some harm; 2 said explicitly they had none.

ReportedPeopleShare
Flushing or head rush after the shot2327%
Allergic reaction, hives or rash1315%
Sleep problems1214%
Injection site reaction911%
Fatigue or lethargy78%
Heart or blood pressure78%
Headache56%
Nausea or stomach upset45%
Anxiety, irritability or low mood34%
Strong hunger (unwanted)34%
Water retention or swelling22%
Joint or muscle pain11%
Numbness, tingling or carpal tunnel symptoms11%
Other, rarer harm1619%
Harms mentioned but not named11%

Share = people / 84.

How severe were the harms?

Of the 59 people who described how strong a harm was, 29 (49%) described it as mild, 27 (46%) as clearly bothersome and 3 (5%) as severe. The strength is the writer's own description, not a doctor's assessment.

Share = people / 59.
Strength of the harm as the writer described itPeopleShare
Mild: minor and manageable2949%
Clearly bothersome: several days, sleep or work affected2746%
Severe: emergency visit, hospital or unable to function35%

Harms known from research and regulators: What are the harms of the CJC-1295 and ipamorelin blend?

How long did people use the CJC-1295 + ipamorelin blend?

52 of 84 people (62%) said how long they had been using it at the time of writing. Where one person wrote several posts, the longest stated time counts.

Share = people / 52.
Stated length of usePeopleShare
Under a week1835%
1-4 weeks1631%
1-3 months1529%
Over 3 months36%

Many people post partway through, often in the first days or as soon as harms start, so short times are over-represented. The numbers describe the writers; they do not say how long it should be used.

Other substances at the same time

33 of 84 people (39%) used other substances at the same time. The most common: retatrutide (11), BPC-157 (8) and GHK-Cu (8). Then the account cannot tell which substance had the effect.

Two substances together, not single substances

We counted accounts in which the writer used CJC-1295 and ipamorelin together themselves: as a ready-made blend or as two substances at the same time. Accounts about only one of them are not included. The single substances have their own summaries, and many people there also used the two together: CJC-1295 user experiences and ipamorelin user experiences. The summaries come from the same archive, so the same post can appear in more than one of them.

The 86 accounts came from 84 different people. The composition sellers declare and its gaps: CJC-1295 + ipamorelin blend: what the research shows. The accounts cannot tell which of the two had an effect.

About dosing

We do not repeat the amounts or ways of use people mention, and we give no dosing or how-to instructions. A safe dose is not known. Doses used in studies, with sources: Dosage of the CJC-1295 and ipamorelin blend in studies. Legal status: Is the CJC-1295 + ipamorelin blend legal in Finland?

What can be concluded?

Harms were reported clearly more often than benefits: the most common were flushing or a head rush after the shot and allergic-type reactions. The most common reported benefit was better sleep. The accounts cannot tell which of the two substances had an effect.

The accounts prove neither that it works nor that it is safe. The writers are self-selected, the product contents are unknown, many used several substances at once, and placebo effects can be large. The research and its evidence levels: CJC-1295 + ipamorelin blend: what the research shows.

Quotes

Short excerpts in the writers’ own words. Writers’ names and links are not shown. We picked quotes from every group: benefit, both benefit and harm, no effect, harms and people who stopped.

Other summaries made with the same method: BPC-157 user experiences, Ipamorelin user experiences, CJC-1295 user experiences, MK-677 user experiences, Tesamorelin user experiences, Sermorelin user experiences, AOD-9604 user experiences and user experiences with collagen and skin peptides.

Content is general information about research, not medical advice. If you have symptoms, contact a healthcare professional.